FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Black conservative unleashes on Obama for ‘constantly whining’ after SCOTUS voting rights decision

Pope Leo places former illegal immigrant in charge of red state diocese

Teen suspect in murder of two bank employees in Kentucky leads police on wild 130 mph chase

Sheriff Grady Judd names Jan. 6 participant, MAGA influencer among 266 arrested in prostitution sting

Progressive Dems Unveil ‘New Affordability Agenda,’ and It’s Just As Bad as You Might Think

Trump Declares Hostilities with Iran ‘Terminated’

Trump tells Congress on 60th day of Iran conflict: ‘Hostilities’ have ‘terminated’

Trump says UFC ‘Claw’ cage construction to begin next week at White House

Alito rips race-based claim in high-stakes migrant protections case at Supreme Court

DHS scorches Pritzker’s ‘sanctuary’ state after child rapist on ICE detainer released

Becerra’s rise in California governor’s race sparks ‘red boxing’ accusations

Trump talks to retirees in first outing since WHCA dinner shooting

GRAPHIC: Fed-up Scott Jennings Snaps, Takes Down Arrogant CNN Guest Who Gets Too Close for Comfort During Heated Debate

Shock Video: Suspicious K9 Had Cole Allen Locked Down Before Handler Pulled Him Away – Literally 2 Seconds Later Allen Made His Move

FBI, Secret Service probe Wisconsin brewery owner over free beer offer after alleged Trump killing attempt

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”